TetraLogic Pharmaceuticals Corp. IPO Info
Company Name: TetraLogic Pharmaceuticals Corp.
Stock Symbol: TLOG
Exchange: NASDAQ
Status: Priced
IPO Date: 12/12/2013
IPO Price:
7.00 (
36.00%)
Underwriters
Amount of Offering: N/A
Number of Shares Offered: 7.15 Mil
Shares Outstanding After Offering: N/A
Valuation: N/A
Company Description
TetraLogic Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that mimic Second Mitochondrial Activator of Caspases, or SMAC-mimetics, and are designed to cause or enable abnormal cells that are resistant to the body's immune system to self-destruct. Birinapant, our clinical-stage product candidate, is currently being tested in Phase 1 and Phase 2 oncology clinical trials for multiple solid tumors and hematological malignancies. Our clinical trials of birinapant have enrolled over 275 subjects.
SEC Filings
News Headlines
